Skip to main content
. 2012 Mar;14(3):169–177. doi: 10.1593/neo.12414

Figure 5.

Figure 5

Pharmacokinetics of 18F-BO. (A) Blood half-life of 18F-BO after intravenous administration. (B) Correlation of PARP expression and 18F-BO uptake in four different ovarian and pancreatic tumor types as determined by immunoblot analysis. (C) Biodistribution of 18F-BO at 2 hours after intravenous administration. (D) Biodistribution of 18F-BO at 18 hours after intravenous administration.